Clinical Trials in Arizona

Showing 5161-5180 of 16,770 trials

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

NCT05971381

To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

Avita Medical109 participantsStarted Aug 2023

Scottsdale, Arizona, United States • Irvine, California, United States • San Diego, California, United States +14 more locations

Active Not RecruitingPhase 331 miles

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

NCT02914535

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in ulcerative colitis (UC).

Ulcerative Colitis

Alfasigma S.p.A.1,173 participantsStarted Feb 2017

Dothan, Alabama, United States • Scottsdale, Arizona, United States • Long Beach, California, United States +320 more locations

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Find Trials by Condition in Arizona

Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

Juvenile Idiopathic Arthritis (JIA) Registry

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD

A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty

Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)

A Study of Ad26.COV2.S in Adults (COVID-19)

Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Framing Eighteen Coils in Cerebral Aneurysms Trial

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis